Twice-Yearly Asthma Biologic Gains UK Approval



The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.
Medscape News UK



Source link : https://www.medscape.com/viewarticle/twice-yearly-asthma-biologic-gains-uk-approval-2025a1000z9n?src=rss

Author :

Publish date : 2025-12-16 13:04:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version